COVID-19 Impact on Global Peripheral Intervention Drug-Eluting Devices Market Insights, Forecast to 2026
Peripheral Intervention Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peripheral Intervention Drug-Eluting Devices market is segmented into
The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peripheral Intervention Drug-Eluting Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Peripheral Intervention Drug-Eluting Devices Market Share Analysis
Peripheral Intervention Drug-Eluting Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Peripheral Intervention Drug-Eluting Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Peripheral Intervention Drug-Eluting Devices business, the date to enter into the Peripheral Intervention Drug-Eluting Devices market, Peripheral Intervention Drug-Eluting Devices product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Peripheral Intervention Drug-Eluting Devices market is segmented into
- Plain Old Balloon Angioplasty (POBA)
- Percutaneous Transluminal Angioplasty (PTA)
- Drug-Eluting Balloons
- Drug-Eluting Stents
The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peripheral Intervention Drug-Eluting Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Peripheral Intervention Drug-Eluting Devices Market Share Analysis
Peripheral Intervention Drug-Eluting Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Peripheral Intervention Drug-Eluting Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Peripheral Intervention Drug-Eluting Devices business, the date to enter into the Peripheral Intervention Drug-Eluting Devices market, Peripheral Intervention Drug-Eluting Devices product introduction, recent developments, etc.
The major vendors covered:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cardinal Health
- B. Braun Melsungen AG
- Biosensors International Group Ltd.
- C.R. Bard, Inc.
- Abbott
- The Lubrizol Corporation
1 STUDY COVERAGE
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
1.4.2 Plain Old Balloon Angioplasty (POBA)
1.4.3 Percutaneous Transluminal Angioplasty (PTA)
1.5 Market by Application
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
1.5.2 Drug-Eluting Balloons
1.5.3 Drug-Eluting Stents
1.6 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
1.6.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Peripheral Intervention Drug-Eluting Devices Production Estimates and Forecasts 2015-2026
2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
2.4 Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
2.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity
3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Production
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue
3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES PRODUCTION BY REGIONS
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Production (2015-2020)
4.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.5.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
5 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES CONSUMPTION BY REGION
5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption
5.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.2.2 North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.4.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.5.2 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.6.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)
6.1.1 Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020)
6.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)
6.1.3 Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)
6.2 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2021-2026)
6.2.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026)
6.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
6.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic plc
8.1.1 Medtronic plc Corporation Information
8.1.2 Medtronic plc Overview and Its Total Revenue
8.1.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic plc Product Description
8.1.5 Medtronic plc Recent Development
8.2 Boston Scientific Corporation
8.2.1 Boston Scientific Corporation Corporation Information
8.2.2 Boston Scientific Corporation Overview and Its Total Revenue
8.2.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Boston Scientific Corporation Product Description
8.2.5 Boston Scientific Corporation Recent Development
8.3 Abbott Laboratories
8.3.1 Abbott Laboratories Corporation Information
8.3.2 Abbott Laboratories Overview and Its Total Revenue
8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Abbott Laboratories Product Description
8.3.5 Abbott Laboratories Recent Development
8.4 Cardinal Health
8.4.1 Cardinal Health Corporation Information
8.4.2 Cardinal Health Overview and Its Total Revenue
8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Cardinal Health Product Description
8.4.5 Cardinal Health Recent Development
8.5 B. Braun Melsungen AG
8.5.1 B. Braun Melsungen AG Corporation Information
8.5.2 B. Braun Melsungen AG Overview and Its Total Revenue
8.5.3 B. Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 B. Braun Melsungen AG Product Description
8.5.5 B. Braun Melsungen AG Recent Development
8.6 Biosensors International Group Ltd.
8.6.1 Biosensors International Group Ltd. Corporation Information
8.6.2 Biosensors International Group Ltd. Overview and Its Total Revenue
8.6.3 Biosensors International Group Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Biosensors International Group Ltd. Product Description
8.6.5 Biosensors International Group Ltd. Recent Development
8.7 C.R. Bard, Inc.
8.7.1 C.R. Bard, Inc. Corporation Information
8.7.2 C.R. Bard, Inc. Overview and Its Total Revenue
8.7.3 C.R. Bard, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 C.R. Bard, Inc. Product Description
8.7.5 C.R. Bard, Inc. Recent Development
8.8 Abbott
8.8.1 Abbott Corporation Information
8.8.2 Abbott Overview and Its Total Revenue
8.8.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Abbott Product Description
8.8.5 Abbott Recent Development
8.9 The Lubrizol Corporation
8.9.1 The Lubrizol Corporation Corporation Information
8.9.2 The Lubrizol Corporation Overview and Its Total Revenue
8.9.3 The Lubrizol Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 The Lubrizol Corporation Product Description
8.9.5 The Lubrizol Corporation Recent Development
8.10 Terumo Corporation
8.10.1 Terumo Corporation Corporation Information
8.10.2 Terumo Corporation Overview and Its Total Revenue
8.10.3 Terumo Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Terumo Corporation Product Description
8.10.5 Terumo Corporation Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Production (2021-2026)
9.3 Key Peripheral Intervention Drug-Eluting Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
11.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
11.3 Peripheral Intervention Drug-Eluting Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
1.4.2 Plain Old Balloon Angioplasty (POBA)
1.4.3 Percutaneous Transluminal Angioplasty (PTA)
1.5 Market by Application
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
1.5.2 Drug-Eluting Balloons
1.5.3 Drug-Eluting Stents
1.6 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
1.6.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Peripheral Intervention Drug-Eluting Devices Production Estimates and Forecasts 2015-2026
2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
2.4 Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
2.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity
3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Production
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue
3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES PRODUCTION BY REGIONS
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Production (2015-2020)
4.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
4.5.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
5 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES CONSUMPTION BY REGION
5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption
5.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.2.2 North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.4.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.5.2 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.6.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)
6.1.1 Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020)
6.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)
6.1.3 Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)
6.2 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2021-2026)
6.2.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026)
6.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
6.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic plc
8.1.1 Medtronic plc Corporation Information
8.1.2 Medtronic plc Overview and Its Total Revenue
8.1.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic plc Product Description
8.1.5 Medtronic plc Recent Development
8.2 Boston Scientific Corporation
8.2.1 Boston Scientific Corporation Corporation Information
8.2.2 Boston Scientific Corporation Overview and Its Total Revenue
8.2.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Boston Scientific Corporation Product Description
8.2.5 Boston Scientific Corporation Recent Development
8.3 Abbott Laboratories
8.3.1 Abbott Laboratories Corporation Information
8.3.2 Abbott Laboratories Overview and Its Total Revenue
8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Abbott Laboratories Product Description
8.3.5 Abbott Laboratories Recent Development
8.4 Cardinal Health
8.4.1 Cardinal Health Corporation Information
8.4.2 Cardinal Health Overview and Its Total Revenue
8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Cardinal Health Product Description
8.4.5 Cardinal Health Recent Development
8.5 B. Braun Melsungen AG
8.5.1 B. Braun Melsungen AG Corporation Information
8.5.2 B. Braun Melsungen AG Overview and Its Total Revenue
8.5.3 B. Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 B. Braun Melsungen AG Product Description
8.5.5 B. Braun Melsungen AG Recent Development
8.6 Biosensors International Group Ltd.
8.6.1 Biosensors International Group Ltd. Corporation Information
8.6.2 Biosensors International Group Ltd. Overview and Its Total Revenue
8.6.3 Biosensors International Group Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Biosensors International Group Ltd. Product Description
8.6.5 Biosensors International Group Ltd. Recent Development
8.7 C.R. Bard, Inc.
8.7.1 C.R. Bard, Inc. Corporation Information
8.7.2 C.R. Bard, Inc. Overview and Its Total Revenue
8.7.3 C.R. Bard, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 C.R. Bard, Inc. Product Description
8.7.5 C.R. Bard, Inc. Recent Development
8.8 Abbott
8.8.1 Abbott Corporation Information
8.8.2 Abbott Overview and Its Total Revenue
8.8.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Abbott Product Description
8.8.5 Abbott Recent Development
8.9 The Lubrizol Corporation
8.9.1 The Lubrizol Corporation Corporation Information
8.9.2 The Lubrizol Corporation Overview and Its Total Revenue
8.9.3 The Lubrizol Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 The Lubrizol Corporation Product Description
8.9.5 The Lubrizol Corporation Recent Development
8.10 Terumo Corporation
8.10.1 Terumo Corporation Corporation Information
8.10.2 Terumo Corporation Overview and Its Total Revenue
8.10.3 Terumo Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Terumo Corporation Product Description
8.10.5 Terumo Corporation Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Production (2021-2026)
9.3 Key Peripheral Intervention Drug-Eluting Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
11.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
11.3 Peripheral Intervention Drug-Eluting Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Peripheral Intervention Drug-Eluting Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Plain Old Balloon Angioplasty (POBA)
Table 5. Major Manufacturers of Percutaneous Transluminal Angioplasty (PTA)
Table 6. COVID-19 Impact Global Market: (Four Peripheral Intervention Drug-Eluting Devices Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Peripheral Intervention Drug-Eluting Devices Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
Table 11. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
Table 15. Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
Table 17. Date of Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
Table 18. Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
Table 19. Main Points Interviewed from Key Peripheral Intervention Drug-Eluting Devices Players
Table 20. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers (2015-2020)
Table 22. Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
Table 24. Peripheral Intervention Drug-Eluting Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Intervention Drug-Eluting Devices Production by Regions (2015-2020) (K Units)
Table 27. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Regions (2015-2020)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions (2015-2020)
Table 30. Key Peripheral Intervention Drug-Eluting Devices Players in North America
Table 31. Import & Export of Peripheral Intervention Drug-Eluting Devices in North America (K Units)
Table 32. Key Peripheral Intervention Drug-Eluting Devices Players in Europe
Table 33. Import & Export of Peripheral Intervention Drug-Eluting Devices in Europe (K Units)
Table 34. Key Peripheral Intervention Drug-Eluting Devices Players in China
Table 35. Import & Export of Peripheral Intervention Drug-Eluting Devices in China (K Units)
Table 36. Key Peripheral Intervention Drug-Eluting Devices Players in Japan
Table 37. Import & Export of Peripheral Intervention Drug-Eluting Devices in Japan (K Units)
Table 38. Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 39. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions (2015-2020)
Table 40. North America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 41. North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 43. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020) (K Units)
Table 52. Global Peripheral Intervention Drug-Eluting Devices Production Share by Type (2015-2020)
Table 53. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020) (Million US$)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)
Table 55. Peripheral Intervention Drug-Eluting Devices Price by Type 2015-2020 (USD/Unit)
Table 56. Global Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 57. Global Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 58. Global Peripheral Intervention Drug-Eluting Devices Consumption Share by Application (2015-2020)
Table 59. Medtronic plc Corporation Information
Table 60. Medtronic plc Description and Major Businesses
Table 61. Medtronic plc Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Medtronic plc Product
Table 63. Medtronic plc Recent Development
Table 64. Boston Scientific Corporation Corporation Information
Table 65. Boston Scientific Corporation Description and Major Businesses
Table 66. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Boston Scientific Corporation Product
Table 68. Boston Scientific Corporation Recent Development
Table 69. Abbott Laboratories Corporation Information
Table 70. Abbott Laboratories Description and Major Businesses
Table 71. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Abbott Laboratories Product
Table 73. Abbott Laboratories Recent Development
Table 74. Cardinal Health Corporation Information
Table 75. Cardinal Health Description and Major Businesses
Table 76. Cardinal Health Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Cardinal Health Product
Table 78. Cardinal Health Recent Development
Table 79. B. Braun Melsungen AG Corporation Information
Table 80. B. Braun Melsungen AG Description and Major Businesses
Table 81. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. B. Braun Melsungen AG Product
Table 83. B. Braun Melsungen AG Recent Development
Table 84. Biosensors International Group Ltd. Corporation Information
Table 85. Biosensors International Group Ltd. Description and Major Businesses
Table 86. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Biosensors International Group Ltd. Product
Table 88. Biosensors International Group Ltd. Recent Development
Table 89. C.R. Bard, Inc. Corporation Information
Table 90. C.R. Bard, Inc. Description and Major Businesses
Table 91. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. C.R. Bard, Inc. Product
Table 93. C.R. Bard, Inc. Recent Development
Table 94. Abbott Corporation Information
Table 95. Abbott Description and Major Businesses
Table 96. Abbott Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Abbott Product
Table 98. Abbott Recent Development
Table 99. The Lubrizol Corporation Corporation Information
Table 100. The Lubrizol Corporation Description and Major Businesses
Table 101. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. The Lubrizol Corporation Product
Table 103. The Lubrizol Corporation Recent Development
Table 104. Terumo Corporation Corporation Information
Table 105. Terumo Corporation Description and Major Businesses
Table 106. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Terumo Corporation Product
Table 108. Terumo Corporation Recent Development
Table 109. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 110. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)
Table 111. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026) (K Units)
Table 112. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 113. North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 114. Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 115. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 119. Peripheral Intervention Drug-Eluting Devices Customers List
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Peripheral Intervention Drug-Eluting Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Plain Old Balloon Angioplasty (POBA)
Table 5. Major Manufacturers of Percutaneous Transluminal Angioplasty (PTA)
Table 6. COVID-19 Impact Global Market: (Four Peripheral Intervention Drug-Eluting Devices Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Peripheral Intervention Drug-Eluting Devices Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
Table 11. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
Table 15. Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
Table 17. Date of Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
Table 18. Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
Table 19. Main Points Interviewed from Key Peripheral Intervention Drug-Eluting Devices Players
Table 20. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers (2015-2020)
Table 22. Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
Table 24. Peripheral Intervention Drug-Eluting Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Intervention Drug-Eluting Devices Production by Regions (2015-2020) (K Units)
Table 27. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Regions (2015-2020)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions (2015-2020)
Table 30. Key Peripheral Intervention Drug-Eluting Devices Players in North America
Table 31. Import & Export of Peripheral Intervention Drug-Eluting Devices in North America (K Units)
Table 32. Key Peripheral Intervention Drug-Eluting Devices Players in Europe
Table 33. Import & Export of Peripheral Intervention Drug-Eluting Devices in Europe (K Units)
Table 34. Key Peripheral Intervention Drug-Eluting Devices Players in China
Table 35. Import & Export of Peripheral Intervention Drug-Eluting Devices in China (K Units)
Table 36. Key Peripheral Intervention Drug-Eluting Devices Players in Japan
Table 37. Import & Export of Peripheral Intervention Drug-Eluting Devices in Japan (K Units)
Table 38. Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 39. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions (2015-2020)
Table 40. North America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 41. North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 43. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020) (K Units)
Table 52. Global Peripheral Intervention Drug-Eluting Devices Production Share by Type (2015-2020)
Table 53. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020) (Million US$)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)
Table 55. Peripheral Intervention Drug-Eluting Devices Price by Type 2015-2020 (USD/Unit)
Table 56. Global Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 57. Global Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 58. Global Peripheral Intervention Drug-Eluting Devices Consumption Share by Application (2015-2020)
Table 59. Medtronic plc Corporation Information
Table 60. Medtronic plc Description and Major Businesses
Table 61. Medtronic plc Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Medtronic plc Product
Table 63. Medtronic plc Recent Development
Table 64. Boston Scientific Corporation Corporation Information
Table 65. Boston Scientific Corporation Description and Major Businesses
Table 66. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Boston Scientific Corporation Product
Table 68. Boston Scientific Corporation Recent Development
Table 69. Abbott Laboratories Corporation Information
Table 70. Abbott Laboratories Description and Major Businesses
Table 71. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Abbott Laboratories Product
Table 73. Abbott Laboratories Recent Development
Table 74. Cardinal Health Corporation Information
Table 75. Cardinal Health Description and Major Businesses
Table 76. Cardinal Health Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Cardinal Health Product
Table 78. Cardinal Health Recent Development
Table 79. B. Braun Melsungen AG Corporation Information
Table 80. B. Braun Melsungen AG Description and Major Businesses
Table 81. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. B. Braun Melsungen AG Product
Table 83. B. Braun Melsungen AG Recent Development
Table 84. Biosensors International Group Ltd. Corporation Information
Table 85. Biosensors International Group Ltd. Description and Major Businesses
Table 86. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Biosensors International Group Ltd. Product
Table 88. Biosensors International Group Ltd. Recent Development
Table 89. C.R. Bard, Inc. Corporation Information
Table 90. C.R. Bard, Inc. Description and Major Businesses
Table 91. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. C.R. Bard, Inc. Product
Table 93. C.R. Bard, Inc. Recent Development
Table 94. Abbott Corporation Information
Table 95. Abbott Description and Major Businesses
Table 96. Abbott Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Abbott Product
Table 98. Abbott Recent Development
Table 99. The Lubrizol Corporation Corporation Information
Table 100. The Lubrizol Corporation Description and Major Businesses
Table 101. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. The Lubrizol Corporation Product
Table 103. The Lubrizol Corporation Recent Development
Table 104. Terumo Corporation Corporation Information
Table 105. Terumo Corporation Description and Major Businesses
Table 106. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Terumo Corporation Product
Table 108. Terumo Corporation Recent Development
Table 109. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 110. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)
Table 111. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026) (K Units)
Table 112. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 113. North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 114. Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 115. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 119. Peripheral Intervention Drug-Eluting Devices Customers List
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2020 & 2026
Figure 3. Plain Old Balloon Angioplasty (POBA) Product Picture
Figure 4. Percutaneous Transluminal Angioplasty (PTA) Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2020 & 2026
Figure 6. Drug-Eluting Balloons
Figure 7. Drug-Eluting Stents
Figure 8. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Revenue 2015-2026 (Million US$)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Production Capacity 2015-2026 (K Units)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Production 2015-2026 (K Units)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 13. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers in 2015
Figure 15. The Top 10 and Top 5 Players Market Share by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Region (2015-2020)
Figure 17. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 18. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 19. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 20. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 21. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 22. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 23. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 24. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 25. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions 2015-2020
Figure 26. North America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 27. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 28. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 29. U.S. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. Canada Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Europe Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 33. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 34. Germany Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. France Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Italy Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Russia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 40. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 41. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions in 2019
Figure 42. China Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Japan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. India Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Australia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Taiwan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Indonesia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Thailand Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Malaysia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Philippines Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Vietnam Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 54. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 55. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 56. Mexico Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Brazil Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Argentina Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 60. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 61. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 62. Turkey Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. U.A.E Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type (2015-2020)
Figure 66. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2019
Figure 67. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
Figure 68. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type in 2019
Figure 69. Global Peripheral Intervention Drug-Eluting Devices Production Market Share Forecast by Type (2021-2026)
Figure 70. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 71. Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Range (2015-2020)
Figure 72. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
Figure 73. Global Peripheral Intervention Drug-Eluting Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 74. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 75. Medtronic plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Biosensors International Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. C.R. Bard, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. The Lubrizol Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Terumo Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 86. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 87. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 88. North America Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 89. North America Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 90. Europe Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 91. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 92. China Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 93. China Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Japan Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 95. Japan Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 97. Peripheral Intervention Drug-Eluting Devices Value Chain
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2020 & 2026
Figure 3. Plain Old Balloon Angioplasty (POBA) Product Picture
Figure 4. Percutaneous Transluminal Angioplasty (PTA) Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2020 & 2026
Figure 6. Drug-Eluting Balloons
Figure 7. Drug-Eluting Stents
Figure 8. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Revenue 2015-2026 (Million US$)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Production Capacity 2015-2026 (K Units)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Production 2015-2026 (K Units)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 13. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers in 2015
Figure 15. The Top 10 and Top 5 Players Market Share by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Region (2015-2020)
Figure 17. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 18. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 19. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 20. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 21. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 22. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 23. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 24. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 25. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions 2015-2020
Figure 26. North America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 27. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 28. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 29. U.S. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. Canada Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Europe Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 33. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 34. Germany Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. France Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Italy Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Russia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 40. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 41. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions in 2019
Figure 42. China Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Japan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. India Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Australia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Taiwan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Indonesia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Thailand Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Malaysia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Philippines Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Vietnam Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 54. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 55. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 56. Mexico Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Brazil Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Argentina Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 60. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 61. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 62. Turkey Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. U.A.E Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type (2015-2020)
Figure 66. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2019
Figure 67. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
Figure 68. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type in 2019
Figure 69. Global Peripheral Intervention Drug-Eluting Devices Production Market Share Forecast by Type (2021-2026)
Figure 70. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 71. Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Range (2015-2020)
Figure 72. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
Figure 73. Global Peripheral Intervention Drug-Eluting Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 74. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 75. Medtronic plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Biosensors International Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. C.R. Bard, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. The Lubrizol Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Terumo Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 86. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 87. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 88. North America Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 89. North America Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 90. Europe Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 91. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 92. China Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 93. China Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Japan Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)
Figure 95. Japan Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 97. Peripheral Intervention Drug-Eluting Devices Value Chain
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed
